2021
DOI: 10.1039/d0cs00173b
|View full text |Cite
|
Sign up to set email alerts
|

Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application

Abstract: Molecular design directions for overcoming the photodynamic therapy challenges.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
541
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 803 publications
(547 citation statements)
references
References 253 publications
5
541
0
1
Order By: Relevance
“…PDT was the first drug/device combination approved by the FDA ( Agostinis et al, 2011 ). Various PSs have been commercialized or used in clinical trials up to date ( Agostinis et al, 2011 ; Zhao et al, 2021 ). One of the most frequently used PSs in the clinic is Photofrin (porfimer sodium).…”
Section: Clinical Applications Of Photodynamic Therapy In Cancermentioning
confidence: 99%
“…PDT was the first drug/device combination approved by the FDA ( Agostinis et al, 2011 ). Various PSs have been commercialized or used in clinical trials up to date ( Agostinis et al, 2011 ; Zhao et al, 2021 ). One of the most frequently used PSs in the clinic is Photofrin (porfimer sodium).…”
Section: Clinical Applications Of Photodynamic Therapy In Cancermentioning
confidence: 99%
“…The organic fluorophores, such as naphthalimides, xanthenes, boron dipyrromethene (BODIPY), and cyanines, can also be designed as photosensitizers for cancer PDT, with high light absorption at relatively long wavelengths and large molar extinction coefficient. Organic fluorophore photosensitizers have low toxicity, good biocompatibility, and long triplet lifetimes, and their fluorescence emission can be used to perform real-time monitoring during PDT treatment [ 40 , 41 ].…”
Section: Pdt Essential Elementsmentioning
confidence: 99%
“…5 Such photo-based modality holds great potential for disease treatment or diagnosis due to its noninvasiveness, spatiotemporal selectivity, and negligible drug resistance. [6][7][8][9][10][11] However, the traditional "always-on" photo-agents including photosensitizers and photothermal chemicals would inevitably provoke a response or phototoxicity to normal tissues, [12][13][14][15][16][17][18] and are unable to achieve precise imaging or therapy nor advance the clinical translation of the photoagents. [19][20][21] The design of activatable photo-agents offers an innovative approach to nonspecic responses.…”
Section: Introductionmentioning
confidence: 99%